Home › Funds › Parallel Advisors, LLC › CORT
Parallel Advisors, LLC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
Parallel Advisors, LLC reported holding 3,902,544 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$449.7M, representing 6.09% of its reported portfolio and ranking #2 among its reported holdings. Parallel Advisors, LLC has disclosed CORT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Parallel Advisors, LLC's CORT position evolved
Parallel Advisors, LLC first disclosed a stake in CORT in Q3 2023 at 3,723,483 shares (US$101.4M). The position peaked in Q3 2026 at 3,902,544 shares, worth US$449.7M. Across 13 filings, Parallel Advisors, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 3,902,544 shares valued at US$449.7M — a reduction of -59,633 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.72M | $101.45M | New |
| Q4 2023 | 3.77M | $122.39M | Add |
| Q1 2024 | 3.82M | $96.12M | Add |
| Q2 2024 | 3.82M | $123.97M | Hold |
| Q3 2024 | 3.81M | $176.50M | Hold |
| Q4 2024 | 3.83M | $192.98M | Hold |
| Q1 2025 | 3.97M | $219.65M | Add |
| Q2 2025 | 3.87M | $284.14M | Reduce |
| Q3 2025 | 3.87M | $321.76M | Hold |
| Q4 2025 | 3.88M | $134.99M | Hold |
| Q1 2026 | 3.98M | $160.33M | Add |
| Q2 2026 | 3.96M | $344.51M | Hold |
| Q3 2026 | 3.90M | $449.69M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$558.9M), TANG CAPITAL MANAGEMENT LLC (US$130.4M), EMERALD ADVISERS, LLC (US$87.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 4.85M sh · $558.88M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- EMERALD ADVISERS, LLC 758.26K sh · $87.37M · Q3 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 473.88K sh · $54.61M · Q3 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on Parallel Advisors, LLC
FAQ
How long has Parallel Advisors, LLC held CORT?
Parallel Advisors, LLC has disclosed CORT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parallel Advisors, LLC's current position in CORT?
As of Q3 2026, Parallel Advisors, LLC holds 3.90M shares of CORT (CORCEPT THERAPEUTICS INC), valued at $449.69M, representing 6.09% of its reported portfolio and ranking #2.
Has Parallel Advisors, LLC been buying or selling CORT?
In the latest 13F filing (Q3 2026), Parallel Advisors, LLC reduced its position in CORT. The position peaked in Q3 2026 at 3.90M shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, TANG CAPITAL MANAGEMENT LLC, EMERALD ADVISERS, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.